ORIGINAL RESEARCH article

Front. Nutr.

Sec. Clinical Nutrition

Volume 12 - 2025 | doi: 10.3389/fnut.2025.1551048

Clinical significance of preoperative nutrition and inflammation assessment tools in gastrointestinal cancer patients undergoing surgery: a retrospective cohort study

Provisionally accepted
  • 1Clinical Nutrition and Dietetics Unit, Candiolo Cancer Institute, FPO-IRCCS, Candiolo (TO), Italy
  • 2Pathology Unit, Candiolo Cancer Institute, FPO-IRCCS, Candiolo (TO), Italy
  • 3Department of Medical Sciences, School of Medicine, University of Turin, Turin, Piedmont, Italy
  • 4Colorectal Surgical Unit, Candiolo Cancer Institute, FPO-IRCCS, Candiolo (TO), Italy
  • 5Department of Medical Oncology, Candiolo Cancer Institute, FPO-IRCCS, Candiolo (TO), Italy

The final, formatted version of the article will be published soon.

Malnutrition and inflammation are associated with poorer surgical outcomes in patients with gastrointestinal cancer. However, it is debated which parameters should be used to assess nutritional and inflammatory status. The aim of the present study was to investigate the prognostic role of specific parameters in predicting postoperative outcomes in this subgroup of patients. This retrospective study included 391 adult patients. Malnutrition risk, was assessed by preoperative validated Malnutrition Universal Screening Tool (MUST) score ≥2, lymphocyte count <900 n/mm^3, albumin value <3.5 g/dL or a combination of the previous two parameters, the Prognostic Nutritional Index (PNI) <45; inflammation was evaluated using preoperative Neutrophil-to-Lymphocyte Ratio (NLR) >5, Platelet-to-Lymphocyte Ratio (PLR) >150 and Lymphocyte-to-Monocyte Ratio (LMR) <5. Statistical analysis was carried out using Univariate and Multivariate Analysis and General Linear Models. Patients with higher preoperative MUST score (p<0.0001), lower albumin level (p=0.0002) or lower PNI (p=0.002) had greater need for parenteral nutrition support and longer hospital stay was reported in patients with higher MUST score (p<0.0001), lower albumin (p<0.0001), lower PNI (p=0.0002), higher NLR (p=0.005) or lower LMR (p=0.027). Complications were more common in patients with higher MUST score (p=0.029), lower albumin (p=0.008) or lower PNI (p=0.006). A MUST score ≥1 or a PNI <45 was associated with a 2-fold risk of postoperative complications (p=0.008; p =0.001), whereas albumin levels <35 g/L were correlated with a 3-fold risk of postsurgical complications (p=0.008). OS was also worse in patients with higher MUST score (p=0.004), PNI (p=0.031) or NLR (p=0.0002), with a 3-fold risk of not surviving at 1 year in patients with a MUST score ≥2 (p=0.003) or NLR ≥5 (p=0.0003). Using general linear models for repeated measures, a preoperative MUST score >1 or albumin levels <35 mg/dl was associated with lower postoperative erythrocyte cells and haemoglobin levels. Multivariate analysis confirmed MUST score, PNI and NLR as independent prognostic factors for survival or postoperative complications. The presence of preoperative malnutrition and/or inflammation is associated with worse postoperative outcomes in patients with gastrointestinal cancer. Early nutritional assessment, including all the above parameters, may allow more tailored intervention to reduce the risk of adverse postoperative outcomes.

Keywords: Nutritional tools, Malnutrition, Inflammation, gastrointestinal cancer, cancer surgery, Nutritional Status, inflammatory status

Received: 24 Dec 2024; Accepted: 23 Apr 2025.

Copyright: © 2025 Casalone, Bellomo, Berrino, Bo, Favaro, Mellano, Fenocchio, Marchiò and Sapino. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Valentina Casalone, Clinical Nutrition and Dietetics Unit, Candiolo Cancer Institute, FPO-IRCCS, Candiolo (TO), Italy

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.